Radiation Oncology CME

Radiation Oncology CME from the Experts

Comprehensive Review of Radiation Oncology consists of 30 one-hour lectures spanning a wide range of radiation therapy treatments that require a complex set of processes: diagnosis, consultation, simulation, contouring target volumes and normal tissue structures, treatment planning, chart review, treatment delivery, quality assurance, and patient follow-up. Authoritative and clinically experienced faculty guide you to more efficient, safer, and higher quality care for each patient. This online CME program will help you to better:

• Describe delivery speed and dose rates of FLASH radiation therapy
• List head and neck tumors for which radiotherapy is beneficial
• Compare radiotherapy for brain metastases and primary brain tumors
• Summarize differences in therapy for non-small versus small cell lung tumor
• Discuss therapy for upper and lower GI malignancies
• Contrast decision making involved in therapy after mastectomy and after breast conservation

Learning Objectives

At the conclusion of this activity, the participant should be able to:

• Define the initial clinical evaluation of a cancer patient – using the physical exam, history, relevant diagnostic studies, and communication with the referring and other physicians involved
• Describe the delivery speed and dose rates of FLASH radiation therapy
• List the head and neck tumors for which radiotherapy is beneficial
• Compare radiotherapy for brain metastases with radiotherapy for primary brain tumors
• Summarize the differences in radiation therapy for non-small cell lung cancer and small cell lung cancer
• Discuss radiation therapy for upper and lower gastrointestinal malignancies
• Contrast the decision making involved in radiation therapy after mastectomy and after breast conservation
• Explain effective treatment delivery for gynecological tumors
• Differentiate the treatment planning required for Hodgkin lymphoma and non-Hodgkin lymphoma
• Compare the doses and beams of various intensities used in stereotactic body radiation therapy used for primary and metastatic gastrointestinal tumors and spinal tumors

Intended Audience

This educational activity was designed for radiation oncologists in practice, radiation oncology residents and fellows.

Learn Now: Advances in Molecular Diagnostics

In Molecular Diagnostics: Cancer Diagnosis and Patient Management, experts in the field review current concepts and up-to-date techniques, delving into the appropriate use of molecular assays for different tumor types to inform diagnosis, prognosis, or treatment using evidence-based guidelines.

Lectures in this online CME course illustrate common diagnostic pitfalls, with additional focus on variant interpretation and the complexity of billing for molecular tests. It’s continuing medical education that will help you to:

• Develop appropriate tissue-handling protocols
• Evaluate cytogenetic and molecular techniques, including next generation sequencing assays
• Recognize cost-effective, time-sensitive approaches to molecular studies, including cell free DNA testing
• Determine the process of clinical interpretation of genetic variation
• Analyze costs and potential sources of revenue for molecular diagnostics programs
• Consider essential and emerging biomarkers in common adult and pediatric solid and liquid tumors

The Osler Radiation Oncology Board Reviews offers learning in a variety of venues and formats.

The Osler Radiation Oncology Course on 5 MP3 CDs w/Electronic Syllabus. Each CD includes a full days’ lectures from the most recent live meeting in MP3 format which you can play on your MP3 player, computer or CD player.

You will also find a number of Radiation Oncology Board Reviews CDs and Books ranging in price from $75 to $290.

Target Audience: Radiation Oncologists

Penn Radiology responds to the constant challenge of Cancer imaging with Oncologic Imaging Essentials.  This activity includes a review of the diagnostic imaging evaluation of common tumors, including breast, head and neck, thoracic and abdominal malignancies.  Current state of the art modalities used for oncologic imaging, including CT, MRI, ultrasound, PET-CT and digital mammography will be discussed.  Emphasis is placed on the role of imaging in staging, treatment and follow up in order to optimize care of oncologic patients.

Each year, more than 290,000 cases of breast cancer are diagnosed, making it the leading cause of cancer among females in the United States. Although earlier screening and more effective treatment options have improved outcomes among people with breast cancer, more than 43,000 people die from this type of cancer each year. Throughout the course of breast cancer management, bone health remains an important consideration. In early breast cancer, chemotherapy-induced ovarian failure and endocrine therapy can contribute to BMD loss and subsequent osteoporosis and fracture. In advanced breast cancer, about 70% of all patients will experience bone metastases, placing patients at risk for SREs. In fact, breast cancer is associated with the highest risk of SREs among all tumor types.

Maintaining bone health in patients with breast cancer requires routine monitoring and proactive management to minimize the risk of BMD loss, osteoporosis, and SREs. Guidelines therefore recommend that patients with non-metastatic breast cancer initiating aromatase inhibitors or other treatment that causes bone loss undergo dual-energy X-ray absorptiometry (DXA) scans to assess baseline BMD. Furthermore, patients at risk for osteoporosis should receive regular follow-up DXA scans to monitor for BMD loss. This represents an opportunity for ongoing education about the need for monitoring to ensure maintenance of optimal bone health.